Sentrydx Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Sentrydx General Information
Description
Developer of cancer diagnostic testing technology intended to improve non-invasive detection and monitoring of cancer. The company's platform offers liquid biopsy-based biomarker analysis and diagnostic kits that detect cancer, enabling clinicians to make informed treatment decisions and improve patient monitoring.
Contact Information
Website
www.sentrydx.comCorporate Office
- 1835 West County Road C
- Suite 25
- Roseville, MN 55113
- United States
Corporate Office
- 1835 West County Road C
- Suite 25
- Roseville, MN 55113
- United States
Sentrydx Timeline
Sentrydx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 01-Jan-2025 | Completed | Startup | |||
| 2. Angel (individual) | 01-Jan-2025 | Completed | Startup | |||
| 1. Grant | 01-Jan-2023 | $275K | Completed | Startup |
Sentrydx Comparisons
Industry
Financing
Details
Sentrydx Competitors (5)
One of Sentrydx’s 5 competitors is Roche Diagnostics, a Corporation company based in Rotkreuz, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Roche Diagnostics | Corporation | Rotkreuz, Switzerland | ||||
| Sysmex | Corporation | Norderstedt, Germany | ||||
| Natera | Formerly VC-backed | Austin, TX | ||||
| Personalis | Formerly VC-backed | Fremont, CA | ||||
| Bio-Rad Laboratories | Corporation | Hercules, CA |
Sentrydx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sentrydx Patents
Sentrydx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026055623-A1 | Improvement to methods for enriching and detecting a target polynucleotide in a sample | Pending | 09-Sep-2024 | ||
| EP-4677112-A2 | Methods for enriching and detecting a target polynucleotide in a sample | Pending | 10-Mar-2023 | ||
| WO-2024191817-A2 | Methods for enriching and detecting a target polynucleotide in a sample | Inactive | 10-Mar-2023 | ||
| WO-2024191817-A3 | Methods for enriching and detecting a target polynucleotide in a sample | Inactive | 10-Mar-2023 | ||
| EP-4402283-A2 | Methods for detecting a target polynucleotide in a sample | Pending | 13-Sep-2021 | C12Q1/6858 |
Sentrydx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sentrydx Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beta.MN | Accelerator/Incubator | |||
| US National Science Foundation | Accelerator/Incubator |
Sentrydx FAQs
-
When was Sentrydx founded?
Sentrydx was founded in 2021.
-
Where is Sentrydx headquartered?
Sentrydx is headquartered in Roseville, MN.
-
What is the size of Sentrydx?
Sentrydx has 6 total employees.
-
What industry is Sentrydx in?
Sentrydx’s primary industry is Diagnostic Equipment.
-
Is Sentrydx a private or public company?
Sentrydx is a Private company.
-
What is Sentrydx’s current revenue?
The current revenue for Sentrydx is .
-
Who are Sentrydx’s investors?
Beta.MN and US National Science Foundation have invested in Sentrydx.
-
Who are Sentrydx’s competitors?
Roche Diagnostics, Sysmex, Natera, Personalis, and Bio-Rad Laboratories are competitors of Sentrydx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
